Biotech Industry Examiner

Menu
Menu
subscribe now
Search
Illumina’s Market Struggles Deepen as U.S.-China Tensions Escalate

Illumina’s Market Struggles Deepen as U.S.-China Tensions Escalate

Illumina, a prominent biotech firm specializing in gene-sequencing technology, is

Illumina Faces Potential $7 Billion Loss from Forced Grail Sale: An Analysis

Illumina Faces Potential $7 Billion Loss from Forced Grail Sale: An Analysis

1. Introduction Background on Illumina and Grail Illumina, Inc. is

EU Sets New Goals for Advancing Biotechnology and Biomanufacturing

EU Sets New Goals for Advancing Biotechnology and Biomanufacturing

Executive Summary The EU Biotech and Biomanufacturing Initiative is a

AI-Powered Drug Repurposing by BioXcel Therapeutics Accelerates Development of New Neuropsychiatric Treatments

AI-Powered Drug Repurposing by BioXcel Therapeutics Accelerates Development of New Neuropsychiatric Treatments

1. Introduction BioXcel Therapeutics is a biopharmaceutical company leveraging artificial

From Early Detection to Tumor “Education”: Syantra’s Bold Bet on cfRNA in Cancer Tech

From Early Detection to Tumor “Education”: Syantra’s Bold Bet on cfRNA in Cancer Tech

€132M for a Dutch Rare-Disease Upstart: Is Europe Quietly Becoming the New Neurology Capital?

€132M for a Dutch Rare-Disease Upstart: Is Europe Quietly Becoming the New Neurology Capital?

From Crypto to Cytoplasm: Brian Armstrong’s NewLimit Targets Hepatocytes for Anti-Aging Breakthrough

From Crypto to Cytoplasm: Brian Armstrong’s NewLimit Targets Hepatocytes for Anti-Aging Breakthrough

Fermenting the Future: Inside the Pentagon’s $80 Million Biomanufacturing Bet—and America’s New Industrial Strategy

Fermenting the Future: Inside the Pentagon’s $80 Million Biomanufacturing Bet—and America’s New Industrial Strategy

Decoding the 100-Year-Old Code: Inside an Ambitious Quest to Unveil the Genetics of Extreme Longevity

Decoding the 100-Year-Old Code: Inside an Ambitious Quest to Unveil the Genetics of Extreme Longevity

MOST POPULAR

News

AbbVie Enters Obesity Drug Market with $2.2B Gubra Licensing Deal
Metsera’s Weight-Loss Drug MET-097i Shows Strong Clinical Results
Light-Based Microcapillary Monitoring Expands Precision in Biotechnology
Novo Holdings Leads $100 Million Series C Financing for Asceneuron

Funding

Aging Science

Impact of Space Travel on Immune Function and Potential Countermeasures
Debate Highlights: Can Aging Be Halted or Reversed? Experts Weigh In
Epigenetic Stability Linked to Lifespan in Mammals, Research Show
New Study Highlights the Impact of Early-Life Tobacco Exposure on Accelerated Aging

Genomics

M&A & Partnerships

Roche’s Bold Foray into Obesity Treatment: A $5.3 Billion Bet on Petrelintide
Merck KGaA in Talks to Acquire U.S. Biotech Firm SpringWorks, Valued at $4 Billion
Pharma Giant Eli Lilly to Buy Biotech Firm Morphic for $3.2 Billion
Orna Therapeutics Acquires ReNAgade Therapeutics to Enhance RNA Medicine Development

Biotech Stocks

Psychology

Innovative Study on Addiction by Mount Sinai and Rockefeller University

Copyright © Industry Examiner 2025 . All rights reserved.

Industry Examiner LLC 166 Geary St. STE 1500 #2640, San Francisco, CA 94108

Facebook Twitter Linkedin Link
Scroll to Top